In Response to Letter to the Editor Regarding: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review
- PMID: 28283940
- PMCID: PMC5440323
- DOI: 10.1007/s13181-017-0610-z
In Response to Letter to the Editor Regarding: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review
Keywords: Cannabinoid hyperemesis syndrome; Cannabis; Cyclic vomiting syndrome; Haloperidol; Marijuana.
Conflict of interest statement
Conflicts of Interest
Dr. Sorensen and Kristen DeSanto declare that they have no conflicts of interest.
Sources of Funding
Dr. Borgelt receives support from the Colorado Department of Public Health and Environment and the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Phillips receives support from NIH on Drug Abuse R15 DA041656 and R01 DA034957, and Dr. Monte receives support from NIH 1 K23 GM110516 and NIH CTSI UL1 TR001082.
Comment on
-
Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.J Med Toxicol. 2017 Mar;13(1):71-87. doi: 10.1007/s13181-016-0595-z. Epub 2016 Dec 20. J Med Toxicol. 2017. PMID: 28000146 Free PMC article.
-
In Response to: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.J Med Toxicol. 2017 Jun;13(2):197. doi: 10.1007/s13181-017-0608-6. Epub 2017 Mar 9. J Med Toxicol. 2017. PMID: 28281175 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical